V5 and GFP Tagging of Viral Gene pp38 of Marek's Disease Vaccine Strain CVI988 Using CRISPR/Cas9 Editing.
Animals
CRISPR-Cas Systems
Chickens
/ virology
Gene Editing
/ methods
Genome, Viral
Green Fluorescent Proteins
/ genetics
Mardivirus
/ genetics
Marek Disease
/ prevention & control
Marek Disease Vaccines
/ genetics
Phosphoproteins
/ genetics
Poultry Diseases
/ prevention & control
Viral Envelope Proteins
/ chemistry
Virus Replication
CRISPR/Cas9
GFP
MDV
V5
pp38
tagging
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
21 02 2022
21 02 2022
Historique:
received:
19
01
2022
revised:
16
02
2022
accepted:
18
02
2022
entrez:
26
2
2022
pubmed:
27
2
2022
medline:
15
3
2022
Statut:
epublish
Résumé
Marek's disease virus (MDV) is a member of alphaherpesviruses associated with Marek's disease, a highly contagious neoplastic disease in chickens. The availability of the complete sequence of the viral genome allowed for the identification of major genes associated with pathogenicity using different techniques, such as bacterial artificial chromosome (BAC) mutagenesis and the recent powerful clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9)-based editing system. Thus far, most studies on MDV genome editing using the CRISPR/Cas9 system have focused on gene deletion. However, analysis of the expression and interactions of the viral proteins during virus replication in infected cells and tumor cells is also important for studying its role in MDV pathogenesis. The unavailability of antibodies against most of the MDV proteins has hindered the progress in such studies. This prompted us to develop pipelines to tag MDV genes as an alternative method for this purpose. Here we describe the application of CRISPR/Cas9 gene-editing approaches to tag the phosphoprotein 38 (pp38) gene of the MDV vaccine strain CVI988 with both V5 and green fluorescent protein (GFP). This rapid and efficient viral-gene-tagging technique can overcome the shortage of specific antibodies and speed up the MDV gene function studies significantly, leading to a better understanding of the molecular mechanisms of MDV pathogenesis.
Identifiants
pubmed: 35216029
pii: v14020436
doi: 10.3390/v14020436
pmc: PMC8879161
pii:
doi:
Substances chimiques
Marek Disease Vaccines
0
Phosphoproteins
0
Viral Envelope Proteins
0
Green Fluorescent Proteins
147336-22-9
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Biotechnology and Biological Sciences Research Council
ID : BBS/E/I/00007038
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BBS/E/I/00007039
Pays : United Kingdom
Références
Vet Microbiol. 2006 Oct 31;117(2-4):154-68
pubmed: 16876339
Proc Natl Acad Sci U S A. 2002 May 14;99(10):7054-9
pubmed: 11997455
Virus Res. 2016 Oct 2;225:33-39
pubmed: 27619840
J Vis Exp. 2019 Jan 7;(143):
pubmed: 30663658
PLoS Pathog. 2011 Feb;7(2):e1001305
pubmed: 21383974
Mol Cells. 2018 Nov 30;41(11):943-952
pubmed: 30486613
Cell. 2014 Jun 5;157(6):1262-1278
pubmed: 24906146
J Virol. 2020 May 4;94(10):
pubmed: 32161176
Virus Genes. 2009 Aug;39(1):102-12
pubmed: 19472043
J Virol. 2005 Sep;79(18):11647-59
pubmed: 16140742
J Virol. 2015 May;89(9):5176-9
pubmed: 25741005
Viruses. 2020 Apr 20;12(4):
pubmed: 32325942
Proc Natl Acad Sci U S A. 2006 Feb 7;103(6):1687-92
pubmed: 16446447
Vaccines (Basel). 2020 Feb 21;8(1):
pubmed: 32098149
J Virol. 2016 Jul 11;90(15):6989-6998
pubmed: 27226370
J Virol. 2004 May;78(9):4753-60
pubmed: 15078957
J Virol. 2014 Dec;88(24):14138-47
pubmed: 25275118
J Exp Med. 2011 Mar 14;208(3):605-15
pubmed: 21383055
Philos Trans R Soc Lond B Biol Sci. 1997 Dec 29;352(1364):1951-62
pubmed: 9451743
Cell. 2013 May 9;153(4):910-8
pubmed: 23643243
Nat Biotechnol. 2014 Apr;32(4):347-55
pubmed: 24584096
Avian Dis. 2013 Jun;57(2 Suppl):464-8
pubmed: 23901762
Avian Dis. 2005 Jun;49(2):199-206
pubmed: 16094823
Science. 2018 Aug 31;361(6405):866-869
pubmed: 30166482
Vaccine. 2018 Jan 29;36(5):716-722
pubmed: 29269155
Avian Dis. 2010 Jun;54(2):862-9
pubmed: 20608531
Arch Virol. 2020 Aug;165(8):1827-1835
pubmed: 32507978
J Virol. 1991 Dec;65(12):6509-15
pubmed: 1658357
J Gen Virol. 2015 Mar;96(Pt 3):626-636
pubmed: 25502645
Sci Rep. 2015 Mar 05;5:8841
pubmed: 25740433
Sci Rep. 2016 Jan 18;6:19176
pubmed: 26777545
Viruses. 2019 Apr 26;11(5):
pubmed: 31027375
Virus Res. 2016 Sep 2;223:197-205
pubmed: 27507009
EMBO J. 1993 Aug;12(8):3277-86
pubmed: 8393785
J Virol. 1993 Jan;67(1):82-92
pubmed: 8380099
Microorganisms. 2021 Aug 08;9(8):
pubmed: 34442761
J Exp Med. 2006 May 15;203(5):1307-17
pubmed: 16651385
J Virol. 2019 Aug 13;93(17):
pubmed: 31189706
Res Vet Sci. 2000 Aug;69(1):17-23
pubmed: 10924389
J Virol. 2005 Apr;79(7):4545-9
pubmed: 15767457
Vaccine. 2008 Mar 28;26(15):1887-92
pubmed: 18313812
Cell. 2013 Sep 12;154(6):1370-9
pubmed: 23992847
J Virol. 2002 Feb;76(4):1959-70
pubmed: 11799190
Nat Biotechnol. 2016 Mar;34(3):339-44
pubmed: 26789497
Microorganisms. 2021 Jan 13;9(1):
pubmed: 33450980
Dev Comp Immunol. 2017 Dec;77:340-349
pubmed: 28899753
J Virol. 2001 Jun;75(11):5159-73
pubmed: 11333897
Sci Rep. 2020 Jul 2;10(1):10919
pubmed: 32616820
J Virol. 2000 Nov;74(21):10176-86
pubmed: 11024146
Virol J. 2011 Jan 05;8:2
pubmed: 21205328
J Virol. 2003 May;77(10):5985-96
pubmed: 12719590
Viruses. 2018 May 24;10(6):
pubmed: 29794970
PLoS One. 2018 Feb 15;13(2):e0192602
pubmed: 29447206
Vaccine. 2017 Aug 24;35(36):4695-4701
pubmed: 28754487
Nat Rev Mol Cell Biol. 2014 Jan;15(1):7-18
pubmed: 24326623
Development. 2014 Dec;141(24):4827-30
pubmed: 25411213
Sci Rep. 2017 May 3;7(1):1478
pubmed: 28469192
Avian Dis. 2004 Jan-Mar;48(1):50-60
pubmed: 15077797
Biotechnol Lett. 2015 Jun;37(6):1265-72
pubmed: 25724716
Science. 2013 Feb 15;339(6121):823-6
pubmed: 23287722
J Virol. 2019 Mar 21;93(7):
pubmed: 30651362
Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11815-20
pubmed: 15289599
Trends Biochem Sci. 2009 Aug;34(8):401-7
pubmed: 19646880